Trials / Conditions / ROS1 Fusion Positive
ROS1 Fusion Positive
4 registered clinical trials studyying ROS1 Fusion Positive — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance NCT07122882 | Chang Gung Memorial Hospital | — |
| Recruiting | Study on the Mechanism of Acquired Resistance of Entrectinib NCT07199959 | Fudan University | — |
| Withdrawn | Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Ca NCT03868423 | Sameek Roychowdhury | Phase 2 |
| Terminated | Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV NCT02587650 | University of California, San Francisco | Phase 2 |